ℹ️ Compiled from public regulatory records · Last regulator revision: September 28, 2023🚩 Report this page
Silicon
Active ingredient
Sold as Silicium Metallicum
US FDA
- Drug class
- -
- Availability
- Over-the-counter
- Routes
- Oral
- Markets covered
- 1
- Products on record
- 1
- FDA reports (12 mo)
- 41
Overview
Silicon is an active pharmaceutical ingredient. The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 1 | September 28, 2023 |
USUnited States· FDA
1 product
1 product on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [1].
Most-reported reactions to the US regulator (12 mo to June 4, 2026): 41 reports total. [2]
- Eye Pain 5
- Death 3
- Nausea 3
- Pneumonia 3
- Arthritis 2
- Diarrhoea 2
- Eye Irritation 2
- Fall 2
- Fatigue 2
- Foreign Body Sensation In Eyes 2
- Ill-Defined Disorder 2
Sources & citations
- [1]FDA DailyMed · 06738254-9a73-f4… · revised September 28, 2023 [PDF]
- [2]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.